Short-term and long-term safety and tolerability of interferon ß-1b in multiple sclerosis.

Reder, Anthony T; Oger, Joel F; Kappos, Ludwig; O'Connor, Paul; Rametta, Mark

Reder, Anthony T; Oger, Joel F; Kappos, Ludwig; O'Connor, Paul; Rametta, Mark.

Afiliación

Reder AT; Department of Neurology, University of Chicago, 5841 S. Maryland Avenue, Chicago 60637-1470, IL, United States. Electronic address: areder@neurology.bsd.uchicago.edu.
Oger JF; University of British Columbia, Neurology Department, 2211 Westbrook Mall, Vancouver, British Columbia, Canada CV6T 2B5. Electronic address: oger@mail.ubc.ca.
Kappos L; Department of Neurology, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland. Electronic address: lkappos@uhbs.ch.
O'Connor P; St. Michael's Hospital, 30 Bond Street, Ontario, Canada M5B 1W8. Electronic address: oconnorp@msh.toronto.on.ca.
Rametta M; Bayer HealthCare Pharmaceuticals, 100 Bayer Boulevard, Whippany 07981, NJ, United States. Electronic address: mark.rametta@bayer.com.

Mult Scler Relat Disord ; 3(3): 294-302, 2014 May.

Article en En | MEDLINE | ID: mdl-25876467

Palabras clave

Interferon ß-1b; Long-term follow-up; Mortality; Multiple sclerosis; Safety; Tolerability

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Mult Scler Relat Disord Año: 2014 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google